Demethyleneberberine

Demethyleneberberine is an inhibitor of NF-kB and TNF-alpha and related targets used in studies of PI3K-Akt-mTOR Signaling and JAK-STAT Signaling and related signaling programs. In practice, this places the compound in experiments that measure growth-factor signaling, survival control, and nutrient-sensing outputs and cytokine-responsive transcriptional signaling and immune regulation in immunology, inflammation, and metabolism models.

By inhibiting NF-kB and TNF-alpha and related targets, Demethyleneberberine can be used to examine growth-factor signaling, survival control, and nutrient-sensing outputs and cytokine-responsive transcriptional signaling and immune regulation. The immunomodulator annotation adds relevance to immune-cell activation, cytokine, and mediator assays, together with downstream-response mapping in the same experimental setting. In immunology, inflammation, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving NF-kB and TNF-alpha and related targets
• Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling and JAK-STAT Signaling and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Immune-cell activation, cytokine, and mediator assays

Overall, Demethyleneberberine is appropriate when a defined chemical perturbant is needed to connect NF-kB and TNF-alpha and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in immunology, inflammation, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.